About: National Hospital Organization Shikoku Cancer Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: National Hospital Organization Shikoku Cancer Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Matsuyama, Japan

Attributes	Values
rdf:type	Item
description	병원 (ko) griya sakit (jv) rumah sakik (min) rumoh sakét (ace) مستشفى (ar) hospital de Xapón (ast) hospital di Jepun (ms) rumah sakit di Jepang (id) জাপানের একটি হাসপাতাল (bn) בית חולים ביפן (he) Krankenhaus in Japan (de) healthcare organization in Matsuyama, Japan (en) 日本の愛媛県松山市にある医療機関 (ja)
rdfs:label	National Hospital Organization Shikoku Cancer Center (en) 独立行政法人国立病院機構四国がんセンター (ja) 四國癌症中心 (zh)
skos:prefLabel	National Hospital Organization Shikoku Cancer Center (en) 独立行政法人国立病院機構四国がんセンター (ja) 四國癌症中心 (zh)
name	National Hospital Organization Shikoku Cancer Center (en) 独立行政法人国立病院機構四国がんセンター (ja) 四國癌症中心 (zh)
ROR ID	wds:Q11571593-926E19A4-D382-4795-84C5-E16D8723BF30
ROR ID	03yk8xt33
image	wds:Q11571593-A41B788D-8480-4585-A11B-90676A6DF668
instance of	wds:Q11571593-299CCD00-BE69-4077-B257-992B5456A3C7 wds:Q11571593-5FAED8AA-0276-49A1-AA6A-DC0BA2CF4523
image
instance of	hospital medical organization
country	wds:Q11571593-E29F245C-84FE-4DBB-836D-40751942AD1D
country	Japan
number of hospital beds	wds:Q11571593-E5ACEE10-161F-4B5F-B09B-FB51CA3A47B3
number of hospital beds	405 (xsd:decimal)
Google Knowledge Graph ID	wds:Q11571593-D0ADBCA5-AAE8-4C21-901A-6711F1D47155
Ringgold ID	wds:Q11571593-52BEB66C-18A8-4C62-BE05-A6EC396775DA
Google Knowledge Graph ID	http://g.co/kg/g/12lnhnr4f
Google Knowledge Graph ID	/g/12lnhnr4f
Ringgold ID	68286
inception	wds:Q11571593-33282869-FCBE-4CD2-9147-063C917737A5
inception	1889-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	National Hospital Organization Shikokugan Center (en) Shikoku Cancer Center (en) 四国がんセンター (ja)
located in the adm...erritorial entity	wds:Q11571593-D80A012C-4E2E-46D2-A4CC-F49736F45B2F
ISNI	wds:Q11571593-E820E82C-A528-4C14-AC71-1C09A8CEF263
VIAF ID	wds:Q11571593-A7DDE9A1-04EB-40CA-ABCA-9478123675BA
postal code	wds:Q11571593-0541FBDE-EA68-49BD-A6CC-6AEAFF6F37DF
NDL Authority ID	wds:Q11571593-E31EFE25-817A-4ADF-A396-BFA593AD87E9
coordinate location	wds:Q11571593-72B02841-96FF-4AC8-B75E-1BCDE0AFF245 wds:Q11571593-B24FCE7C-95A9-4D7D-B1CA-3C293AC9D4FC
WorldCat Identities ID (superseded)	wds:Q11571593-28CDEBB6-155F-443C-B188-8D573C701C03
official website	wds:Q11571593-B84C1EE9-94ED-4778-85B3-E54189868F53
VIAF ID	http://viaf.org/viaf/258846286
NDL Authority ID	http://id.ndl.go.jp/auth/ndlna/01036952
located in the adm...erritorial entity	Matsuyama
ISNI	0000000406188403
VIAF ID	258846286
postal code	791-0280
NDL Authority ID	01036952
coordinate location	POINT(132.84111 33.797529) POINT(132.841111 33.797222)
WorldCat Identities ID (superseded)	viaf-258846286
official website	http://www.shikoku-cc.go.jp/
GRID ID	wds:Q11571593-110AE468-248F-4B4D-9704-CCBD276684AD
parent organization	wds:Q11571593-10586800-7308-4CC5-A040-C60F66B9DC97
GRID ID	grid.415740.3
parent organization	National Hospital Organization
is owl:sameAs of	National Hospital Organization Shikoku Cancer Center
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q11571593 https://ja.wikipedia.org/wiki/%E5%9B%BD%E7%AB%8B%E7%97%85%E9%99%A2%E6%A9%9F%E6%A7%8B%E5%9B%9B%E5%9B%BD%E3%81%8C%E3%82%93%E3%82%BB%E3%83%B3%E3%82%BF%E3%83%BC
is research site of	A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors) Phase II Study of ABI-007 for Gastric Cancer Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Study of REGN2810 in Adults With Cervical Cancer Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer Paclitaxel in Treating Patients With Ovarian Stromal Cancer Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection Atezolizumab Trial in Endometrial Cancer - AtTEnd Japan Phase 2 Study of Niraparib in Patients With Advanced, Relapsed Ovarian Cancer Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Patients With Relapsed Ovarian Cancer Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A) A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software